Conversely, ccRCC patients with higher expression levels of Cyclin E1 and MMP9 had significantly shorter survival time than patients with low Cyclin E1 and MMP9 expression levels (Fig. 2J, M). Here, CCNE1 is linked to nonpapillary renal cell carcinoma.